LIGAND PHARMACEUTICALS INC - FORM 10-K - EX-23.2 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM-BDO SEIDMAN, LLP - March 3, 2010

Attached files

file filename
10-K - FORM 10-K - LIGAND PHARMACEUTICALS INCd10k.htm
EX-21.1 - SUBSIDIARIES OF REGISTRANT - LIGAND PHARMACEUTICALS INCdex211.htm
EX-32.1 - CERTIFICATION OF BY PRINCIPAL EXECUTIVE OFFICER - SECTION 906 - LIGAND PHARMACEUTICALS INCdex321.htm
EX-31.2 - CERTIFICATION OF BY PRINCIPAL FINANCIAL OFFICER - SECTION 302 - LIGAND PHARMACEUTICALS INCdex312.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM-GRANT THORNTON LLP - LIGAND PHARMACEUTICALS INCdex231.htm
EX-32.2 - CERTIFICATION OF BY PRINCIPAL FINANCIAL OFFICER - SECTION 906 - LIGAND PHARMACEUTICALS INCdex322.htm
EX-10.361 - AMENDMENT TO DISCOVERY COLLABORATION AGREEMENT - LIGAND PHARMACEUTICALS INCdex10361.htm
EX-31.1 - CERTIFICATION OF BY PRINCIPAL EXECUTIVE OFFICER - SECTION 302 - LIGAND PHARMACEUTICALS INCdex311.htm

Exhibit 23.2

Consent of Independent Registered Public Accounting Firm

Ligand Pharmaceuticals Incorporated

San Diego, California

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 No. 333-131029 and 333-160132 of Ligand Pharmaceuticals Incorporated of our report dated February 28, 2008, relating to the December 31, 2007 consolidated financial statements which is incorporated by reference in this Annual Report on Form 10-K. We also consent to the incorporation by reference of our report dated February 28, 2008 relating to the financial statement schedule, which appears in this Form 10-K.

/s/ BDO Seidman, LLP

San Diego, California

March 3, 2010

Stock widget

Investing forum

LIGAND PHARMACEUTICALS INC Reports

Also read